Skip to main content
Glama

Roblox

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already provide readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, so the safety profile is covered. The description goes well beyond that by disclosing graceful degradation when GLEIF/OpenFIGI are unavailable, explicit unresolved-identifier reporting, candidate-returning behavior for ambiguous matches, and the internal cascading lookup behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense with necessary edge-case guidance, and the opening examples immediately communicate intent. It is structured as one continuous block with heavy parentheticals, which slightly hurts scannability, but every sentence contributes useful information about when and how to call the tool.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return behavior, and it does: expected identifiers per type, unresolved fields, figi_candidates on ambiguity, optional enrichment, and degradation semantics. The agent has enough information to invoke the tool correctly and interpret its response.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds crucial guidance not present in the schema: pass the entity name only, never the full noun phrase, with the concrete counterexample 'NEW YORK ST DORM AUTH revenue bonds'. It also enriches value semantics by listing accepted input forms per type (ticker, CIK, ISIN, name; brand or generic drug name) and the ISIN-to-LEI resolution path.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings and states the core verb: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It covers supported entity types (company, drug) and the specific identifiers (CIK, LEI, FIGI, RxCUI), making it clearly distinct from siblings like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID', which gives a strong when-to-use directive. It does not explicitly name sibling tools as alternatives, but it explains edge cases like ambiguous names resolving to figi_candidates, so the agent understands when not to expect a single assertion.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Roblox toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.1/5.0
Disambiguation4/5

Most tools have distinct purposes, especially within the Roblox and Pipeworx domains. However, the three variants of ask_pipeworx (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) are very similar and could cause confusion, as could deep_research vs ask_pipeworx.

Naming Consistency3/5

Naming conventions are mixed: snake_case (user_followers_count), verb_noun with underscores (ask_pipeworx), and camelCase (recall, forget). Roblox tools follow a consistent 'user_' prefix, but Pipeworx tools lack a uniform pattern.

Tool Count2/5

41 tools is excessive for a server named 'Roblox'. The majority of tools are Pipeworx data utilities, which are unrelated to the server's apparent focus. This overloading undermines coherence.

Completeness3/5

Coverage within the Roblox domain is basic (user profiles, friends, games) but misses common features like asset details or group management. Pipeworx appears comprehensive for data lookups, but the overall set lacks unified domain completeness.

Resources